Background: Single anastomosis duodeno-ileal bypass (SADI) has emerged as a safe and effective bariatric procedure. Its simplicity and robust weight loss outcomes have contributed to its increasing popularity. While traditionally performed as an inpatient procedure, recent trends towards ambulatory surgery have prompted interest in outpatient SADI.
Objective: This study aims to assess the safety profile of outpatient SADI cases reported in the MBSAQIP database, providing valuable insights into the feasibility and potential benefits of this approach.
Methods: This retrospective study analyzed data from the MBSAQIP database. Patients who underwent SADI and were discharged on the same day of surgery were included. Demographic, medical history, and postoperative outcomes, including readmission, complication, and reoperation rates, were analyzed.
Results: A total of 192 patients who underwent SADI and were discharged on the same day of surgery were included. The majority of patients were female, with a mean age of 44.3 years. Thirty-day readmission and reoperation rates were 4.69% and 2.6%, respectively.
Conclusion: Outpatient SADI can be a safe and effective option for appropriately selected patients, with similar complication and readmission rates to inpatient SADI and other outpatient bariatric procedures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11695-025-07691-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Single anastomosis duodeno-ileal bypass (SADI) has emerged as a safe and effective bariatric procedure. Its simplicity and robust weight loss outcomes have contributed to its increasing popularity. While traditionally performed as an inpatient procedure, recent trends towards ambulatory surgery have prompted interest in outpatient SADI.
View Article and Find Full Text PDFCharacterization of trends in preoperative hemoglobin A1c testing prior to metabolic and bariatric surgery: a retrospective, observational study.
Perioper Med (Lond)
January 2025
Department of Surgery, Yale School of Medicine, New Haven, CT, 06510, USA.
Background: Irrespective of baseline diabetes status, preoperative hemoglobin A1c (A1C) influences perioperative care in patients undergoing metabolic and bariatric surgery (MBS). Accordingly, the American Society of Metabolic and Bariatric Surgery (ASMBS) endorses that patients undergoing MBS should receive a preoperative A1C test. We aimed to assess the proportion of MBS patients who received a preoperative A1C test and determine whether baseline diabetes status influences receipt of a test.
View Article and Find Full Text PDFRobotic sleeve gastrectomy has higher complication rates compared to laparoscopic: 8-year analysis of robotic versus laparoscopic primary bariatric surgery.
Surg Obes Relat Dis
December 2024
Division of Minimally Invasive Surgery, Department of Surgery, University of California San Diego, San Diego, California.
Background: Robotic-assisted bariatric surgery is growing rapidly. The optimal approach to minimize complications remains unclear.
Objective: Assess robot utilization and compare 30-day outcomes for laparoscopic and robotic primary sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database.
IVC filter use in patients with a history of venous thromboembolism undergoing bariatric surgery: a MBSAQIP study.
Surg Endosc
December 2024
Hartford Hospital Metabolic and Bariatric Surgery Program, 80 Seymour Street, Hartford, CT, 06106, USA.
Background: Research on the use of prophylactic inferior vena cave filter (IVCF) placement prior to metabolic and bariatric surgery (MBS) in high risk patients has yielded conflicting results. We evaluated thrombotic events and mortality in patients with a history of venous thromboembolism (VTE) who underwent IVCF placement in anticipation of MBS.
Methods: We queried the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database for all patients undergoing primary sleeve gastrectomy or Roux-en-Y gastric bypass from 2015 to 2019 with a history of VTE.
Development of venous thromboembolic event risk calculator for metabolic and bariatric surgery patients to reduce mortality.
Surg Obes Relat Dis
October 2024
Geisinger Health, Danville, Pennsylvania.
Background: Venous Thromboembolic events (VTE) after Metabolic and Bariatric Surgery (MBS) result in significant morbidity and are the leading cause of mortality.
Objective: The objective of this study was to identify patients who are at a high risk for developing VTE and who may benefit from extended chemoprophylaxis following MBS.
Setting: Multi-institutional study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!